Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals Read more
Chairs post an invitation letter for the 12th Annual Pre-Filled Syringes and Injectable Drugs conference Read more
Hovione Announces Successful End-of-phase 2 Meeting With the FDA and Outlines Phase 3 Program for Minocycline Topical Gel Read more
Boehringer Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases Read more
Takeda and Lundbeck announce Ministry of Health, Labour and Welfare (MHLW) approval of Trintellix in Japan Read more